GB1577670A - 1-aryloxy-2 - hydroxy - 3 - aminopropanes and process for their preparation - Google Patents

1-aryloxy-2 - hydroxy - 3 - aminopropanes and process for their preparation Download PDF

Info

Publication number
GB1577670A
GB1577670A GB22051/77A GB2205177A GB1577670A GB 1577670 A GB1577670 A GB 1577670A GB 22051/77 A GB22051/77 A GB 22051/77A GB 2205177 A GB2205177 A GB 2205177A GB 1577670 A GB1577670 A GB 1577670A
Authority
GB
United Kingdom
Prior art keywords
phenyl
radical
grams
propoxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB22051/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of GB1577670A publication Critical patent/GB1577670A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
GB22051/77A 1976-05-25 1977-05-25 1-aryloxy-2 - hydroxy - 3 - aminopropanes and process for their preparation Expired GB1577670A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2623314A DE2623314C2 (de) 1976-05-25 1976-05-25 1-Aryloxy-2-Hydroxy-3-aminopropane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
GB1577670A true GB1577670A (en) 1980-10-29

Family

ID=5978907

Family Applications (1)

Application Number Title Priority Date Filing Date
GB22051/77A Expired GB1577670A (en) 1976-05-25 1977-05-25 1-aryloxy-2 - hydroxy - 3 - aminopropanes and process for their preparation

Country Status (18)

Country Link
JP (1) JPS5312827A (nl)
AT (1) AT354421B (nl)
AU (1) AU511704B2 (nl)
BE (1) BE855041A (nl)
CA (1) CA1108633A (nl)
CH (5) CH637105A5 (nl)
DE (1) DE2623314C2 (nl)
DK (1) DK227177A (nl)
ES (1) ES458957A1 (nl)
FI (1) FI67698C (nl)
FR (1) FR2353520A1 (nl)
GB (1) GB1577670A (nl)
HU (1) HU179198B (nl)
IL (1) IL52148A (nl)
IT (1) IT1077193B (nl)
NL (1) NL7705587A (nl)
SE (1) SE440903B (nl)
ZA (1) ZA773120B (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001016124A1 (de) * 1999-09-01 2001-03-08 Dr. Willmar Schwabe Gmbh & Co. Zimtsäurenitrile, verfahren zu ihrer herstellung und verwendung

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415622A1 (fr) * 1978-01-25 1979-08-24 Lipha Amino alcools derives de l'ortho-hydroxy cinnamate de methyle applicables notamment comme medicaments
DE2824764A1 (de) * 1978-06-06 1979-12-20 Hoechst Ag Neue pyridylpiperazinderivate und verfahren zu ihrer herstellung
DE2961251D1 (en) * 1978-08-15 1982-01-14 Smithkline Beckman Corp A method of preparing a 2-hydroxy-3-isopropyl or a 2-hydroxy-3-tert-butylaminopropyl aromatic ether
FR2459235A1 (fr) * 1979-06-14 1981-01-09 Sanofi Sa Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique
JPH0629833B2 (ja) * 1984-06-15 1994-04-20 株式会社島津製作所 疲労試験機
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
CA2716369C (en) 1999-05-24 2013-05-14 Mitsubishi Tanabe Pharma Corporation Phenoxypropylamine compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA945172A (en) * 1969-02-21 1974-04-09 Imperial Chemical Industries Limited Alkanolamine derivatives
FR2132570B1 (nl) * 1971-04-09 1974-08-02 Lipha
BE791650R (fr) * 1971-11-18 1973-05-21 Ici Ltd Derives d'alkanolamines.
ES411826A1 (es) * 1973-02-20 1976-01-01 Liade Sa Lab Procedimiento de obtencion de 1-ariloxi - 2 - propanolami- nas farmacologicamente activos.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001016124A1 (de) * 1999-09-01 2001-03-08 Dr. Willmar Schwabe Gmbh & Co. Zimtsäurenitrile, verfahren zu ihrer herstellung und verwendung

Also Published As

Publication number Publication date
ATA370177A (de) 1979-06-15
IT1077193B (it) 1985-05-04
NL7705587A (nl) 1977-11-29
JPS6214545B2 (nl) 1987-04-02
ZA773120B (en) 1978-04-26
FI67698C (fi) 1985-05-10
CA1108633A (en) 1981-09-08
AU2543477A (en) 1978-11-30
CH637105A5 (en) 1983-07-15
CH637109A5 (en) 1983-07-15
BE855041A (fr) 1977-11-25
AU511704B2 (en) 1980-09-04
DE2623314A1 (de) 1977-12-08
JPS5312827A (en) 1978-02-04
FR2353520A1 (fr) 1977-12-30
AT354421B (de) 1979-01-10
SE440903B (sv) 1985-08-26
HU179198B (en) 1982-09-28
CH637107A5 (en) 1983-07-15
SE7706059L (sv) 1977-11-26
DE2623314C2 (de) 1984-08-02
IL52148A0 (en) 1977-07-31
FI771630A (nl) 1977-11-26
ES458957A1 (es) 1978-07-16
FI67698B (fi) 1985-01-31
IL52148A (en) 1982-07-30
CH640507A5 (en) 1984-01-13
DK227177A (da) 1977-11-26
FR2353520B1 (nl) 1980-07-25
CH637108A5 (en) 1983-07-15

Similar Documents

Publication Publication Date Title
US4059621A (en) Substituted benzamido propanolamines
CA1327576C (en) Phenoxyacetic acid amide derivatives and their use in the treatment of obesity and related conditions
US4191765A (en) 1-Aryloxy-2-hydroxy-3-aminopropanes
PL69767B1 (en) 11-substituted 5 11-dihydro-6h-pyrido(2 3-b)(1 4)benzodiazepin-6-ones [us3660380a]
BRPI0617636A2 (pt) composto, composição farmacêutica, e, uso de um composto
DE2822227A1 (de) Spiroaminderivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und verwendung derselben
US3318896A (en) Production of 12-substituted-6, 7, 8, 9, 10, 11-hexahydrocycloocta[b]quinolines
EP0034284B1 (en) Piperazine derivative, processes for preparing the same and therapeutic compositions containing it
US4129565A (en) Isocarbostyril derivatives
US5852019A (en) Pyrimidinylpyrazole derivatives
US3922266A (en) Aryl ketones and production thereof
GB1577670A (en) 1-aryloxy-2 - hydroxy - 3 - aminopropanes and process for their preparation
FI62052C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 4-aminofenyletanolaminer med saerskilt beta2-mimetisk och ala1-blockerande verkan
US3979390A (en) Butyrophenone derivatives and production thereof
IL23338A (en) N-phenylpiperazine compounds
US4146629A (en) 4-arylpiperidine derivatives
US4983633A (en) Amide compounds, process for preparing the same, and composition for activating gastric motor function containing the same
US4140713A (en) Phenylethanolamine therapeutic agents
IE48979B1 (en) Carbazoles
CA1195328A (en) Phenoxypropanolamine derivatives
EP0187700B1 (en) Novel aminoalkyl substituted urea derivatives, acid addition salts thereof and enatiomers
US3830806A (en) Derivatives of 1-phenoxy-3-amino-propan-2-ol
NO162907B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive bis-(piperazinyl-resp. homopiperazinyl)-alkaner.
CA1080219A (en) Piperazine derivatives and a process for the preparation thereof
CA1044234A (en) 7-(hydroxyphenyl)pyrido(3,4-d)pyridazines

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
746 Register noted 'licences of right' (sect. 46/1977)
PCNP Patent ceased through non-payment of renewal fee